AstraZeneca severe asthma treatment Tezspire gets Japanese nod

UK: AstraZeneca has announced that Tezspire (tezepelumab) has been approved in Japan for the treatment of bronchial asthma in patients with severe or refractory disease in whom asthma symptoms cannot...

Related Keywords

Japan ,Tokyo ,Japanese ,Hironori Sagara ,Astrazeneca ,Showa University School Of Medicine ,Japanese Ministry Of Health ,Japanese Ministry ,Medicine Division ,Respiratory Medicine ,Showa University School ,Executive Vice President ,New England Journal ,Astrazeneca News ,Tezspire ,Tezepelumab ,Bronchial Asthma ,Asthma , ,